KOBIOLABS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 23 Oct 2025)
What this means for you
Registered since 02 Jul 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87603889
- Registration number
- 5791315
- Mark type
- Design + words
- Filed
- 11 Sept 2017
- Published for opposition
- 16 Apr 2019
- Registered
- 02 Jul 2019
- Attorney of record
- Hun Joon Kim
Goods and services
- Class 005 — Pharmaceuticals: [ Pharmaceutical and veterinary preparations, namely, preparations for the prevention of inflammatory bowel disease, irritable bowel syndrome, constipation, diarrhea, metabolic syndrome, obesity, diabetes, hypertension, insulin resistance, high blood cholesterol, high blood Triglycerides, cardiovascular disease, autoimmune disease, atopic dermatitis, arthritis, asthma, allergy, Crohn's disease, mental diseases, neurodegenerative disease, cancer, infectious disease, liver disease and inflammatory disease; Microorganism preparations, namely, nutritive substances for microorganisms for medical or veterinary purposes; Microorganism preparations, namely, microorganism cells for medical or veterinary purposes; Cultures of microorganisms for medical purposes; Biological preparations for medical or veterinary purposes, namely, preparations for the treatment of inflammatory bowel disease, irritable bowel syndrome, constipation, diarrhea, metabolic syndrome, obesity, diabetes, hypertension, insulin resistance, high blood cholesterol, high blood Triglycerides, cardiovascular disease, autoimmune disease, atopic dermatitis, arthritis, asthma, allergy, Crohn's disease, mental diseases, neurodegenerative disease, cancer, infectious disease, liver disease and inflammatory disease; Dietetic food supplements; Dietetic foods adapted for medical purposes; Nutraceuticals for medical purposes, namely, for the treatment of inflammatory bowel disease, irritable bowel syndrome, constipation, diarrhea, metabolic syndrome, obesity, diabetes, hypertension, insulin resistance, high blood cholesterol, high blood Triglycerides, cardiovascular disease, autoimmune disease, atopic dermatitis, arthritis, asthma, allergy, Crohn's disease, mental diseases, neurodegenerative disease, cancer, infectious disease, liver disease and inflammatory disease ]
- Class 042 — Scientific and technological services: [ Consultation in the field of health risk assessment, namely, predicting health risks of individuals with regard to medical disease; ] Drug discovery services; [ Provision of scientific information and advice in the field of microorganisms; DNA testing for scientific research purposes; DNA analysis for scientific research purposes; DNA sequencing analysis for scientific research purposes; consultation and providing information in the fields of biomedicine for scientific and research purposes; Consultancy in analysis of biology sequence processing for medical research purposes; Consultancy in analysis of genomics for medical research purposes; ] scientific research in the fields of medicine, health and pharmacology [ ; Consultation and providing information in the fields of and pharmacology ]
- Class 044 — Medical, beauty and agricultural services: [ Performing diagnosis of diseases; Provision of genetic testing for medical treatment purposes; Provision of gene therapy for medical treatment purposes; DNA screening for medical purposes; Consultation and providing information in the fields of medicine and health ]
Owner
- KoBioLabs, Inc., Seoul, KR
- KoBioLabs, Inc., Seoul, KR
- KoBioLabs, Inc., Seoul, KR
Prosecution history
- 23 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 23 Oct 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 17 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Jun 2025 — TEAS SECTION 8 & 15 RECEIVED
- 27 Nov 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Nov 2024 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 27 Nov 2024 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 27 Nov 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Nov 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Nov 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 Nov 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 02 Jul 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 02 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 10 May 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Apr 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED